GMRE:NYE-Global Medical REIT Inc (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 7.81

Change

+0.11 (+1.43)%

Market Cap

N/A

Volume

0.27M

Analyst Target

USD 14.79
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-02 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

+0.39 (+0.26%)

USD 92.95B
VTR Ventas Inc

+1.02 (+1.56%)

USD 29.73B
DOC Healthpeak Properties Inc

+0.03 (+0.17%)

USD 13.10B
CTRE CareTrust REIT Inc.

-0.53 (-1.82%)

USD 5.43B
AHR American Healthcare REIT, Inc.

+0.74 (+2.33%)

USD 4.79B
NHI National Health Investors Inc

+0.50 (+0.66%)

USD 3.54B
LTC LTC Properties Inc

-0.46 (-1.29%)

USD 1.55B
UHT Universal Health Realty Income..

+0.73 (+1.90%)

USD 0.53B
CHCT Community Healthcare Trust Inc

+0.15 (+0.89%)

USD 0.45B
GMRE-PA Global Medical REIT Inc

-0.12 (-0.49%)

USD 0.40B

ETFs Containing GMRE

KBWY Invesco KBW Premium Yield.. 3.93 % 0.35 %

+0.08 (+0%)

USD 0.20B
SDEF 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.17% 40% F 70% C-
Dividend Return 2.72% 100% F 86% B+
Total Return 3.89% 47% F 77% C+
Trailing 12 Months  
Capital Gain -7.02% 13% F 28% F
Dividend Return 10.00% 100% F 95% A
Total Return 2.98% 20% F 42% F
Trailing 5 Years  
Capital Gain -19.15% 38% F 17% F
Dividend Return 42.96% 77% C+ 84% B
Total Return 23.81% 38% F 32% F
Average Annual (5 Year Horizon)  
Capital Gain -6.12% 33% F 11% F
Dividend Return 0.73% 33% F 27% F
Total Return 6.86% 87% B+ 90% A-
Risk Return Profile  
Volatility (Standard Deviation) 23.78% 47% F 42% F
Risk Adjusted Return 3.08% 33% F 24% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.